top of page
Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules. Interventional procedures guidance
Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules. Interventional procedures guidance
Citation
What Has NICE Said? | Information for the Public | Ultrasound-Guided Percutaneous Radiofrequency Ablation for Benign Thyroid Nodules | Guidance | NICE. 22 June 2016, https://www.nice.org.uk/guidance/ipg562/ifp/chapter/What-has-NICE-said.
URL
Abstract
Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules is safe enough and works well enough for use in the NHS.
Before this procedure is used, the thyroid nodule must be tested to make sure it is benign (not cancerous). A thin needle is used to take a sample of tissue from the nodule, to check for cancer cells. Ultrasound‑guided percutaneous radiofrequency ablation should not be done if the nodule is cancerous.
Current evidence on the safety and efficacy of ultrasound guided percutaneous radiofrequency ablation for benign thyroid nodules is adequate to support the use of this procedure provided that standard arrangements are in place for clinical governance, consent and audit.
Conclusion
Benefits
The evidence that NICE looked at for ultrasound‑guided percutaneous radiofrequency ablation to treat thyroid nodules showed that the procedure was safe enough and worked well enough to be used in the NHS. The 7 studies that NICE looked at involved about 2,500 patients.
Generally, they showed the following benefits:
nodules were smaller
some patients were able to reduce or stop taking drugs for overactive thyroid (hyperthyroidism)
cosmetic appearance was better and most people had less severe symptoms after the procedure.
Key Words
Contact Us
Address
2320 N. Third Street
Phoenix, AZ 85004
Contact
tel: 602-889-2923
fax: 602-889-2925 / 602-889-2926
Opening Hours
Mon - Thurs
7:30 am – 4:30 pm
Friday
7:30 am – 4:00 pm
Closed M-F
12:00 - 1:00 pm Lunch
bottom of page